Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How effective is moxifloxacin for the first-line treatment of patients with Helicobacter pylori infection?

Nature Clinical Practice Gastroenterology & Hepatology volume 2, pages 450–451 (2005)Cite this article

boxed-textNista EC et al. (2005) Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 21: 1241–1247

Quinolone-based Helicobacter pylori eradication regimens might be useful in geographical areas with a relatively high level of H. pylori resistance to clarithromycin but further studies are required to confirm this

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Megraud F (2004) Basis for the management of drug-resistant Helicobacter pylori infection. Drugs 64: 1893–1904

    Article  CAS  Google Scholar 

  2. Labenz J et al. (1991) Ciprofloxacin–omeprazole combination therapy for eradication of Helicobacter pylori. Z Gastroenterol 29: 143–145

    CAS  PubMed  Google Scholar 

  3. Nista EC et al. (2003) Levofloxacin-based triple therapy vs quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther 18: 627–633

    Article  CAS  Google Scholar 

  4. di Caro S (2002) Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. Aliment Pharmacol Ther 16: 527–532

    Article  CAS  Google Scholar 

  5. Toracchio S and Marzio L (2003) Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002. Dig Liver Dis 35: 541–545

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. University Professor at the Department of Microbiology and Hygiene, University Hospital Freiburg, Freiburg, Germany

    Manfred Kist

Authors
  1. Manfred Kist
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kist, M. How effective is moxifloxacin for the first-line treatment of patients with Helicobacter pylori infection?. Nat Rev Gastroenterol Hepatol 2, 450–451 (2005). https://doi.org/10.1038/ncpgasthep0288

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0288

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing